# Symptom-Oriented, Connectome-Informed Deep Brain Stimulation for Asymmetric Dystonic Tremor: Unilateral Ventral Intermediate Nucleus (VIM) DBS Targeting a Tremor-Dominant Network

**Authors:** Olga Mateo-Sierra, Javier Ricardo Pérez-Sánchez, Beatriz De la Casa-Fages, María Teresa Del Castillo, Pilar Fernández, Pascual Elvira, José Paz, Francisco Grandas

PMC · DOI: 10.3390/jcm15041666 · 2026-02-23

## TL;DR

A new deep brain stimulation approach targeting tremor networks improves severe dystonic tremor more effectively than traditional methods.

## Contribution

Demonstrates a symptom-focused, brain network-based DBS strategy for asymmetric dystonic tremor.

## Key findings

- Unilateral VIM DBS reduced tremor severity by 73.5% in a patient with treatment-resistant dystonic tremor.
- Functional improvements included restored handwriting and bimanual motor tasks after stimulation.
- Clinical benefits remained stable for six months without adverse effects.

## Abstract

Background: Deep brain stimulation (DBS) has traditionally followed diagnosis-driven, nucleus-centered targeting paradigms. Increasing evidence supports a circuit-based framework in which clinical outcomes depend on modulation of symptom-relevant networks rather than diagnostic labels alone. This approach is particularly relevant in mixed movement disorder phenotypes such as dystonic tremor, where the most disabling symptom may not align with the conventional surgical target. Methods: We report a clinically illustrative single case treated using a symptom-oriented, connectome-informed DBS strategy. Clinical phenotype, tremor severity, functional impairment, prior medical and botulinum toxin treatments, and longitudinal outcomes were systematically reviewed. DBS target selection prioritized the dominant, treatment-refractory symptom rather than the underlying dystonia diagnosis. Surgical planning incorporated high-resolution MRI with patient-specific thalamic segmentation using Brainlab Brain Elements®, followed by postoperative lead localization and volume of tissue activated visualization with the SureTune™ platform. Results: A 54-year-old left-handed woman with long-standing cervical dystonia developed a severe, markedly asymmetric dystonic tremor predominantly affecting the left upper limb, resulting in profound functional disability. Instead of conventional bilateral globus pallidus internus DBS, unilateral right ventral intermediate nucleus (VIM) DBS was selected to engage tremor-related cerebellothalamic circuits. Rapid and marked improvement was observed, with tremor severity reduced to mild levels within 15 days after stimulation onset. At 6-month follow-up, overall tremor severity improved from 49 to 13 points on the Fahn–Tolosa–Marin Tremor Rating Scale, corresponding to a 73.5% reduction. This improvement was associated with restoration of legible handwriting, independent feeding and drinking, and recovery of bimanual fine motor function. Clinical benefit remained stable throughout follow-up, without stimulation-related adverse effects. Conclusions: This case illustrates the feasibility of a symptom-oriented, connectome-informed DBS strategy in selected patients with dystonic tremor. When symptom expression and network involvement are markedly asymmetric, selective unilateral modulation of the tremor-dominant circuit may achieve meaningful and durable functional improvement. Further studies are needed to assess the generalizability of this approach.

## Linked entities

- **Diseases:** cervical dystonia (MONDO:0000481)

## Full-text entities

- **Diseases:** functional (MESH:D003291), tonic cervical dystonia (MESH:D014103), axial or head tremor (MESH:D006258), cerebral atrophy (MESH:D001284), VIM (MESH:D006555), injury to (MESH:D014947), dystonia (MESH:D004421), splenius capitis (MESH:D014006), Parkinson's disease (MESH:D010300), extensor hallucis longus (MESH:D009127), clinical disability (MESH:D009069), Functional impairment (MESH:D003072), tonic dystonic (MESH:D004829), dystonic disorder (MESH:D020821), essential and dystonic tremor (MESH:D020329), spasms (MESH:D013035), Dystonic tremor (MESH:D014202)
- **Chemicals:** clonazepam (MESH:D002998), zonisamide (MESH:D000078305), VIM (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941799/full.md

---
Source: https://tomesphere.com/paper/PMC12941799